» Articles » PMID: 16956976

Crystal Structure of Human Histone Lysine-specific Demethylase 1 (LSD1)

Overview
Specialty Science
Date 2006 Sep 8
PMID 16956976
Citations 124
Authors
Affiliations
Soon will be listed here.
Abstract

Lysine-specific demethylase 1 (LSD1) was recently identified as the first histone demethylase that specifically demethylates monomethylated and dimethylated histone H3 at K4. It is a component of the CoREST and other corepressor complexes and plays an important role in silencing neuronal-specific genes in nonneuronal cells, but the molecular mechanisms of its action remain unclear. The 2.8-A-resolution crystal structure of the human LSD1 reveals that LSD1 defines a new subfamily of FAD-dependent oxidases. The active center of LSD1 is characterized by a remarkable 1,245-A3 substrate-binding cavity with a highly negative electrostatic potential. Although the protein core of LSD1 resembles other flavoenzymes, its enzymatic activity and functions require two additional structural modules: an N-terminal SWIRM domain important for protein stability and a large insertion in the catalytic domain indispensable both for the demethylase activity and the interaction with CoREST. These results provide a framework for further probing the catalytic mechanism and the functional roles of LSD1.

Citing Articles

Mechanistic insights into novel cyano-pyrimidine pendant chalcone derivatives as LSD1 inhibitors by docking, ADMET, MM/GBSA, and molecular dynamics simulation.

Gupta A, Parveen D, Azam F, Shaquiquzzaman M, Akhter M, Jaremko M Biochem Biophys Rep. 2025; 41:101937.

PMID: 40028038 PMC: 11871483. DOI: 10.1016/j.bbrep.2025.101937.


The multifaceted role of post-translational modifications of LSD1 in cellular processes and disease pathogenesis.

Li Y, Wang B, Zheng Y, Kang H, He A, Zhao L Genes Dis. 2025; 12(3):101307.

PMID: 40028036 PMC: 11870172. DOI: 10.1016/j.gendis.2024.101307.


A CRISPR-Cas9 screen reveals genetic determinants of the cellular response to decitabine.

Zhang P, Zhang Z, Wang Y, Du W, Song X, Lai W EMBO Rep. 2025; .

PMID: 39930152 DOI: 10.1038/s44319-025-00385-w.


Role of lysine-specific demethylase 1 in immunotherapy of gastric cancer: An update.

Ren Y, Gong Y, Zhao H, You D, Li Z, Wang S Chin J Cancer Res. 2025; 36(6):669-682.

PMID: 39802899 PMC: 11724184. DOI: 10.21147/j.issn.1000-9604.2024.06.06.


Discovery of novel dual-target inhibitors of LSD1/EGFR for non-small cell lung cancer therapy.

Wei Y, Sun M, Zhang R, Wang L, Yang L, Shan C Acta Pharmacol Sin. 2025; .

PMID: 39753983 DOI: 10.1038/s41401-024-01439-w.


References
1.
Ballas N, Battaglioli E, Atouf F, Andres M, Chenoweth J, Anderson M . Regulation of neuronal traits by a novel transcriptional complex. Neuron. 2001; 31(3):353-65. DOI: 10.1016/s0896-6273(01)00371-3. View

2.
Binda C, Newton-Vinson P, Hubalek F, Edmondson D, Mattevi A . Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders. Nat Struct Biol. 2001; 9(1):22-6. DOI: 10.1038/nsb732. View

3.
Yamane K, Toumazou C, Tsukada Y, Erdjument-Bromage H, Tempst P, Wong J . JHDM2A, a JmjC-containing H3K9 demethylase, facilitates transcription activation by androgen receptor. Cell. 2006; 125(3):483-95. DOI: 10.1016/j.cell.2006.03.027. View

4.
Shi Y, Lan F, Matson C, Mulligan P, Whetstine J, Cole P . Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004; 119(7):941-53. DOI: 10.1016/j.cell.2004.12.012. View

5.
Brunger A, Adams P, Clore G, DeLano W, Gros P, Grosse-Kunstleve R . Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr. 1998; 54(Pt 5):905-21. DOI: 10.1107/s0907444998003254. View